Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[International multicentre trials. Practical experiences o planning and executing]

J Brynskov

    Nordisk Medicin
    |January 1, 1988
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Commentary: antibodies reacting with the infliximab Fab portion--something new? Authors' reply.

    Alimentary pharmacology & therapeutics·2013
    Same author

    Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease.

    Alimentary pharmacology & therapeutics·2013
    Same author

    Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls.

    Beneficial microbes·2012
    Same author

    Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD.

    Alimentary pharmacology & therapeutics·2012
    Same author

    Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease.

    Alimentary pharmacology & therapeutics·2012
    Same author

    Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease.

    Alimentary pharmacology & therapeutics·2011
    Same journal

    [Nordisk Medicine 1929-1998. Thanks and farewell!].

    Nordisk medicin·1999
    Same journal

    [Scientific fraud and misconduct--need for comprehensive terminology].

    Nordisk medicin·1999
    Same journal

    [Labor-market for Scandinavian physicians in the year 2000--dearth or surplus?].

    Nordisk medicin·1999
    Same journal

    [Internet in consultation--headed for trouble?].

    Nordisk medicin·1999
    Same journal

    [Interpretation of questionnaires. An translation method problem].

    Nordisk medicin·1999
    Same journal

    [Assessment of patients' health status--review of the literature and assessment methods].

    Nordisk medicin·1999
    See all related articles